Industry Supports Transparency On Proposed CMS Prior Authorization Rule
Industry trade groups applaud CMS’s proposal to increase transparency for prior authorization approvals but are asking for expedited timeframes to provide care.
You may also be interested in...
Greater Transparency For Medicare Advantage Program Needed, MDMA Says
Medtech industry groups call for greater transparency and oversight for Medicare Advantage plans.
News We’re Watching: Disease X Act, Abiomed Recall, TAVR AI Cleared
This week, the bipartisan Disease X Act for pandemic preparedness was introduced in the US House of Representatives; Abiomed Impella pumps were the subject of a class I recall; Dasi Simulations and Endologix landed FDA clearances; and the FDA warned against the use of Getinge/Maquet Oxygenators.
DTA Standardizes Definition Of Digital Therapeutics
The Digital Therapeutics Alliance (DTA) released a standardized definition and guidance for digital therapeutics during its annual meeting in Washington, DC. The move comes as part of a push toward standardization for the fast-changing field.